Literature DB >> 16493083

Visualization of p53(264-272)/HLA-A*0201 complexes naturally presented on tumor cell surface by a multimeric soluble single-chain T cell receptor.

Xiaoyun Zhu1, Heather J Belmont, Shari Price-Schiavi, Bai Liu, Hyung-il Lee, Marilyn Fernandez, Richard L Wong, Janette Builes, Peter R Rhode, Hing C Wong.   

Abstract

Intracellular Ags are processed into small peptides that are presented on cell surfaces in the context of HLA class I molecules. These peptides are recognized by TCRs displayed by CD8+ T lymphocytes (T cells). To date, direct identification and quantitation of these peptides has relied primarily on mass spectrometry analysis, which is expensive and requires large quantities of diseased tissues to obtain useful results. Here we demonstrate that multimerization of a soluble single-chain TCR (scTCR), recognizing a peptide from p53 presented in the context of HLA-A2.1, could be used to directly visualize and quantitate peptide/MHC complexes on unmanipulated human tumor cells. Tumor cells displaying as few as 500 peptide/MHC complexes were readily detectable by flow cytometry. The scTCR/multimers exhibited exquisite recognition capability and could distinguish peptides differing in as little as a single amino acid. We also demonstrate that scTCR/multimers could specifically stain human tumors generated in mice, as well as tumors obtained from patient biopsies. Thus, scTCR/multimers represent a novel class of immunostaining reagents that could be used to validate, quantitate, or monitor epitope presentation by cancer cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16493083     DOI: 10.4049/jimmunol.176.5.3223

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation.

Authors:  Sarah E Henrickson; Thorsten R Mempel; Irina B Mazo; Bai Liu; Maxim N Artyomov; Huan Zheng; Antonio Peixoto; Michael P Flynn; Balimkiz Senman; Tobias Junt; Hing C Wong; Arup K Chakraborty; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2008-01-20       Impact factor: 25.606

2.  Interleukin-15:Interleukin-15 receptor α scaffold for creation of multivalent targeted immune molecules.

Authors:  Richard L Wong; Bai Liu; Xiaoyun Zhu; Lijing You; Lin Kong; Kai-Ping Han; Hyung-Il Lee; Pierre-Andre Chavaillaz; Moonsoo Jin; Yi Wang; Peter R Rhode; Hing C Wong
Journal:  Protein Eng Des Sel       Date:  2010-12-21       Impact factor: 1.650

3.  Phase I trial of ALT-801, an interleukin-2/T-cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignancies.

Authors:  Mayer N Fishman; John A Thompson; Gregory K Pennock; Rene Gonzalez; Luz M Diez; Adil I Daud; Jeffery S Weber; Bee Y Huang; Shamay Tang; Peter R Rhode; Hing C Wong
Journal:  Clin Cancer Res       Date:  2011-10-12       Impact factor: 12.531

4.  Novel human interleukin-15 agonists.

Authors:  Xiaoyun Zhu; Warren D Marcus; Wenxin Xu; Hyung-il Lee; Kaiping Han; Jack O Egan; Jason L Yovandich; Peter R Rhode; Hing C Wong
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

5.  Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cells.

Authors:  Marc R Theoret; Cyrille J Cohen; Azam V Nahvi; Lien T Ngo; Kimberly B Suri; Daniel J Powell; Mark E Dudley; Richard A Morgan; Steven A Rosenberg
Journal:  Hum Gene Ther       Date:  2008-11       Impact factor: 5.695

6.  Can oligomeric T-cell receptor be used as a tool to detect viral peptide epitopes on infected cells?

Authors:  Nadia Anikeeva; Tatiana Mareeva; Wei Liu; Yuri Sykulev
Journal:  Clin Immunol       Date:  2008-10-08       Impact factor: 3.969

7.  Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors.

Authors:  Gary C Pien; Etiena Basner-Tschakarjan; Daniel J Hui; Ashley N Mentlik; Jonathan D Finn; Nicole C Hasbrouck; Shangzhen Zhou; Samuel L Murphy; Marcela V Maus; Federico Mingozzi; Jordan S Orange; Katherine A High
Journal:  J Clin Invest       Date:  2009-05-11       Impact factor: 14.808

8.  Amino-terminal extended peptide single-chain trimers are potent synthetic agonists for memory human CD8+ T cells.

Authors:  Beatriz M Carreno; Michelle Becker-Hapak; Megan Chan; Wen-Rong Lie; Xiaoli Wang; Ted H Hansen; Gerald P Linette
Journal:  J Immunol       Date:  2012-05-09       Impact factor: 5.422

Review 9.  The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy.

Authors:  Sylvia Annabel Dass; Rehasri Selva Rajan; Gee Jun Tye; Venugopal Balakrishnan
Journal:  Hum Vaccin Immunother       Date:  2021-05-14       Impact factor: 3.452

10.  Binding of TCR multimers and a TCR-like antibody with distinct fine-specificities is dependent on the surface density of HLA complexes.

Authors:  Jianrong L Low; Anneta Naidoo; Gladys Yeo; Adam J Gehring; Zi Zong Ho; Yin Hoe Yau; Susana G Shochat; David M Kranz; Antonio Bertoletti; Gijsbert M Grotenbreg
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.